Live Breaking News & Updates on Athira pharma

Stay informed with the latest breaking news from Athira pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Athira pharma and stay connected to the pulse of your community

One Athira Pharma Insider Raised Their Stake In The Previous Year

Viewing insider transactions for Athira Pharma, Inc.'s ( NASDAQ:ATHA ) over the last year, we see that insiders were...

Athira-pharma , Nsider-transactions , Nsider-ownership , Nsiders , Ndrew-gengos ,

Recursion, Canaan, Metsera and more—Chutes & Ladders

Recursion, Canaan, Metsera and more—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Italy , Utah , United-states , Italian , British , Le-goff , Cytosite-biopharma , Najat-khan , Corinne-le-goff

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease -April 11, 2024 at 07:02 am EDT

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer's Disease -April 11, 2024 at 07:02 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Seattle , Washington , United-states , Janine-bogris , Mark-litton , Securities-exchange , Athira-pharma-inc , Twitter , Instagram , Linkedin , Facebook , Exchange-commission

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

Presentation to highlight therapeutic potential of Athira’s small molecules targeting the neurotrophic HGF system in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s...

Colorado , United-states , Washington , Seattle , Denver , American , Athira-pharma , Janine-bogris , Kevin-church , Instagram , Securities-exchange , American-academy-of-neurology

Tech Moves: Instacart COO lands at Microsoft in AI product role; ZoomInfo accounting chief departs

Tech Moves: Instacart COO lands at Microsoft in AI product role; ZoomInfo accounting chief departs
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Minnesota , United-states , Rachel-lennington , Ruffalo-noel-levitz , Asha-sharma , Cameron-hyzer , Justin-althoff , Paula-tomlinson , Athira-pharma , Prasadh-cadambi , Fred-hutch , Justin-marquart

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Portugal , United-states , Lisbon , Lisboa , Washington , Seattle , American , Mark-litton , Sharay-setti , Hans-moebius , Rachel-lenington , Sherif-reda

Short Interest in Athira Pharma, Inc. (NASDAQ:ATHA) Grows By 39.6%

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 717,600 shares, an increase of 39.6% from the January 15th total of 513,900 shares. Based on an average daily volume of 331,300 shares, the short-interest ratio […]

Athira-pharma , Jacobs-levy-equity-management-inc , Renaissance-technologies , Nasdaq , Dimensional-fund-advisors , Athira-pharma-company-profile , Perceptive-advisors-llc , Athira-pharma-inc , Get-free-report , Director-perceptive-advisors-llc , Fund-advisors , Levy-equity-management

2 "Strong Buy" Penny Stocks That Could Rally All the Way to $10 (or More)

Are penny stocks a must-have or a must-avoid? Well, that depends on who you ask. There’s no middle ground when it comes to these tickers trading for less than $5 per share; those on the Street are either fans or harsh critics. Both sides make sense. The naysayers argue that the bargain price is just too good to be true, with it potentially indicating there are problems hiding beneath the surface like weak fundamentals or overwhelming headwinds. However, the investors that are pro-penny stocks ju

Athira-pharma , Thomas-shrader , David-nierengarten , Wall-street , Vor-biopharma , Strong-buy , Best-stocks , Ematopoietic-stem-cells , Linical-trial , Enny-stocks , Or

Athira's ALS drug boosts survival, slows motor decline in mice

Athira's ALS drug boosts survival, slows motor decline in mice
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Athira-pharma , Kevin-church , South-korean ,